FDA declines to approve Valeant's plaque psoriasis lotion

(Reuters) - Valeant Pharmaceuticals International Inc's plaque psoriasis treatment did not get approval from U.S. health regulators, a set back for the company which had high hopes for the lotion.

Source: Reuters: Health - June 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news